NCM
TLSI icon

Nantahala Capital Management’s TriSalus Life Sciences TLSI Stock Holding History

Nantahala Capital Management’s Portfolio TLSI Stock Details TLSI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.55M Sell
1,000,000
-1,070,827
-52% -$4.25M 0.15% 111
2026
Q1 		$8.28M Hold
2,070,827
– – 0.3% 77
2025
Q4 		$14.5M Buy
2,070,827
+30,582
+1% +$171K 0.48% 51
2025
Q3 		$9.49M Buy
2,040,245
+40,245
+2% +$188K 0.33% 72
2025
Q2 		$10.9M Buy
+2,000,000
New +$10.7M 0.43% 51

Other funds holding TLSI

FLAM
First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Cerity Partners
Cerity Partners New York $82.7B AUM 28.53% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
GGHC
Gilder Gagnon Howe & Co New York $9.69B AUM 55.7% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
WPC
White Pine Capital Bloomington, Minnesota $423M AUM 67.01% 1-Year Est. Return
TSW
Thompson Siegel & Walmsley Richmond, Virginia $5.57B AUM 9.46% 1-Year Est. Return
KCM
Kennedy Capital Management St Louis, Missouri $5.65B AUM 61.31% 1-Year Est. Return

Nantahala Capital Management's TLSI Position: Q2 2026 in Review

Nantahala Capital Management reduced its TriSalus Life Sciences (TLSI) stake by 52% in Q2 2026, selling an estimated $4.25M and leaving 1,000,000 shares worth $4.55M. The position accounts for 0.15% of the portfolio, ranked #111.

Nantahala Capital Management first reported a position in TLSI in Q2 2025 and has held it in 5 quarters since. The position peaked at $14.5M in Q4 2025. 79 funds tracked by Wall St. Rank hold TLSI as of Q2 2026.

  • Nantahala Capital Management held 1,000,000 shares of TriSalus Life Sciences worth $4.55M as of Q2 2026.
  • Nantahala Capital Management sold 1,070,827 TriSalus Life Sciences shares in Q2 2026, an estimated $4.25M.
  • TriSalus Life Sciences made up 0.15% of Nantahala Capital Management's portfolio in Q2 2026, its #111 holding.
  • Nantahala Capital Management first reported a position in TriSalus Life Sciences in Q2 2025 and has held it in 5 quarters since.
  • Nantahala Capital Management's TriSalus Life Sciences position peaked at $14.5M in Q4 2025.
  • 79 funds tracked by Wall St. Rank held TriSalus Life Sciences as of Q2 2026.

Based on Nantahala Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.